Market Introduction
Antibiotic is a group of medicines that fights bacterial infections, and sometimes protozoan diseases. Moreover, they are used to treat many diseases such as strep throat, urinary tract infections, sinus infections, pneumonia, eye & ear infections, and others. Antibiotics are also called antimicrobials or antibacterial. After the discovery of the antibiotic penicillin in 1920, various other antibiotic compounds have been used to treat several bacterial infections.
Market Overview and Dynamics
The Asia Pacific antibiotics market is expected to reach US$ 15,784.01 million by 2027 from US$ 11,591.97 million in 2019. The market is estimated to grow with a CAGR of 4.2% from 2020 to 2027. Factors driving the market growth areprevalence of infectious diseases and consolidated government initiatives in emerging economies. However, the tedious and expensive process associated with antibiotic development and impact of COVID-19 pandemic is likely to have a negative impact on market growth.
Key Market Segments
By drug class, the cephalosporins segment accounted for the largest market share in the Asia Pacificantibiotics market in 2019. In terms of action mechanism, the cell wall synthesis inhibitors segment is expected to hold the largest share of the antibiotics market by 2027..
Major Sources and Companies Listed
Some of the major primary and secondary sources for Antibioticsmarket included in the report are, World Health Organization (WHO), Central Drugs Standard Control Organisation (CDSCO), Center for Disease Dynamics, Economics & Policy (CDDEP), and others.
Reasons to buy the report
ASIA PACIFICANTIBIOTICSMARKET SEGMENTATION
By Drug Class
By Action Mechanism
By Geography
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 11,591.97 Million |
| Market Size by 2027 | US$ 15,784.01 Million |
| CAGR (2020 - 2027) | 4.2% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Drug Class
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Antibiotics Market is valued at US$ 11,591.97 Million in 2019, it is projected to reach US$ 15,784.01 Million by 2027.
As per our report Asia Pacific Antibiotics Market, the market size is valued at US$ 11,591.97 Million in 2019, projecting it to reach US$ 15,784.01 Million by 2027. This translates to a CAGR of approximately 4.2% during the forecast period.
The Asia Pacific Antibiotics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Antibiotics Market report:
The Asia Pacific Antibiotics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Antibiotics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Antibiotics Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)